Hamdan Bin Rashid Al Maktoum Foundation Organises Webinar To Enhance Breast Cancer Awareness And Education

The Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences recently hosted a successful scientific webinar. This event focused on the latest developments in breast cancer diagnosis and treatment. It attracted global experts and a diverse audience of healthcare professionals, researchers, and oncology specialists. The webinar highlighted recent medical innovations and scientific advancements in breast cancer care.

Participants explored the ongoing challenges faced by physicians in bridging the gap between research and clinical practice. A major challenge discussed was the complexity of breast cancer diagnosis, driven by the genetic and biological diversity of the disease. Accurate diagnosis requires advanced techniques like molecular profiling and genetic testing to tailor treatment plans to each patient's unique characteristics.

During the webinar, speakers emphasised the importance of advanced imaging techniques such as MRI and CT scans. These, along with genetic profiling, are crucial in determining the exact stage of the disease and identifying tumor types. However, experts noted that these technologies are not yet fully integrated into clinical practice worldwide, contributing to a gap between research and real-world application.

Dr. Salama Al Muhairi, Director of Medical Excellence at Hamdan Bin Rashid Al Maktoum Foundation, highlighted their commitment to continuous medical education. She stressed the importance of raising awareness about advancements in fighting complex diseases like cancer. Dr. Al Muhairi stated, "At Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences, we are committed to fostering sustainable healthcare solutions by creating opportunities for positive cultural shifts in the medical community's approach to challenging diseases."

The webinar featured notable contributions from Prof. Melinda Telli from Stanford Cancer Institute, who presented advancements in targeted therapies for triple-negative and hereditary breast cancer. Dr. Abeer Al Sayegh from Sultan Qaboos Comprehensive Cancer Center discussed genomics' role in improving patient care through personalised treatment solutions. Prof. Mehran Habibi from Northwell Health shared insights into surgical innovations like oncoplastic breast surgery.

Dr. Mouza Al Ameri expertly moderated the session with her extensive experience enriching discussions on best practices in treatment and research. The session concluded with recommendations aimed at strengthening collaboration among healthcare professionals to implement research findings in clinical settings.

Commitment to Continuous Education

Dr. Al Muhairi also mentioned that understanding breast cancer's complexity requires physicians to stay informed about new tools and techniques continually. She added that "Advanced imaging, molecular profiling, and targeted therapies are no longer optional but are essential elements of precise and effective care." This ongoing education is vital for achieving optimal outcomes.

The event underscored the need for interdisciplinary collaboration among healthcare professionals to improve patient care quality through knowledge exchange. The foundation aims to provide an interactive platform where professionals can share expertise while staying updated on breast cancer diagnosis and treatment advancements.

The webinar concluded with key recommendations expected to enhance patient care regionally by implementing recent research findings in clinical practice effectively.

With inputs from WAM